PFIZER INC Construction in Progress, Gross
PFIZER INC (PFE) had Construction in Progress, Gross of $1.10 billion as of 2013-12-31, per its 10-K filed 2014-02-28.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:ConstructionInProgressGross · last filed 2014-02-28
- 2013-12-31: Construction in Progress, Gross $1.10B.
- 2012-12-31: Construction in Progress, Gross $957.00M; Construction in Progress, Gross as first filed $1.11B.
- 2011-12-31: Construction in Progress, Gross $1.29B; Construction in Progress, Gross as first filed $1.14B.
- 2010-12-31: Construction in Progress, Gross $999.00M; Construction in Progress, Gross as first filed $1.03B.
| Period end | Construction in Progress, Gross | Construction in Progress, Gross as first filed |
|---|---|---|
| 2013-12-31 | $1.10B 10-K · filed 2014-02-28 | |
| 2012-12-31 | $957.00M 10-K · filed 2014-02-28 | $1.11B 10-K · filed 2013-02-28 |
| 2011-12-31 | $1.29B 10-K · filed 2013-02-28 | $1.14B 10-K · filed 2012-02-28 |
| 2010-12-31 | $999.00M 10-K · filed 2012-02-28 | $1.03B 10-K · filed 2011-02-28 |
| 2009-12-31 | $1.97B 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |